The anthrapyrazoles
- 30 November 1995
- journal article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 21 (6), 541-552
- https://doi.org/10.1016/0305-7372(95)90017-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer.Journal of Clinical Oncology, 1991
- MitoxantroneAnti-Cancer Drugs, 1990
- Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell lineCancer Chemotherapy and Pharmacology, 1990
- The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patientsCancer Chemotherapy and Pharmacology, 1989
- The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processesBiochemical Pharmacology, 1987
- In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles)Biochemical Pharmacology, 1985
- The mechanism of action of quinone antibioticsMolecular and Cellular Biochemistry, 1983
- Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen MetabolitesJCI Insight, 1980
- Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agentsBiochemical Pharmacology, 1979
- Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycinBiochemical and Biophysical Research Communications, 1977